Isolation and Purification of an Antitumor Metabolite from Alternaria brassicicola SW-3, the Cause of Brassica Black Leaf Spot Disease.

Phytopathogenic fungus Alternaria brassicicola SW-3가 생산하는 항암활성 물질의 분리 정제

  • 나여정 (서울여자대학교 식품ㆍ미생물공학과) ;
  • 이방숙 (서울여자대학교 화학과) ;
  • 남궁성건 (서울여자대학교 화학과) ;
  • 정동선 (서울여자대학교 식품ㆍ미생물공학과)
  • Published : 2002.03.01

Abstract

An antitumor substance was purified from the culture filtrate of phytopathogenic fungus Alternaria brassicicola SW-3 isolated from soil of a chinese cabbage patch, and its characteristics were investigated. Antitumor activity of A. brassicicola SW-3 was measured by MTT assay. The cytotoxic activity against human cancer cell line was detected in the culture filtrate of A. brassicicola SW-3, but no activity found in mycelium. Antitumor substance was isolated from the culture broth by ethyl acetate extraction and purified by silica gel column chromatography. Structure of the purified compound was analyzed by the instrumental analysis such as $^1$H-NMR, $^{13}$ C-NMR and IR spectroscopy. The purified fungal metabolite of an A. brassicicola SW-3, consists of 11 carbon chain with two hydroxyl groups and two epoxides which is identical to depudecin. The $IC_{50}$/ values of the active compound identified as depudecin were $69\mu$g/mL and $57\mu$g/mL against mouse melanoma B16BL6 cell line, and human hepatoma SK-HEP1 cell line, respectively.

국내 토양에서 분리한 식물성 병원균인 Alternaria brassicicola SW-3리 항암활성 물질 생산능을 조사하고, 활성물질을 분리 정제하여 구조를 확인하였다. A. brassicicola SW-3는potato dextrose broth를 이용하여 15$^{\circ}C$에서 2주간 진탕 배양한 다음, MTT assay를 실시하여 항암활성을 확인하였으며, 배양여액 중의 항암물질은 ethyl acetate로 추출하고, silica gel column chromatography로 정제하여 무색의 oily product를 얻었다(수율 22mg/m1). 분리된 물질은 물이나 hexane에는 녹지 않고, chloroform, ethyl acetate, ethanol 등에는 잘 녹는 특징을 보였으며, , $IR^{1}$H-NMR, $^{13}$C-NMR 등을 통해 구조를 분석한 결과, 최근에 일본에서 분리되어 항암효과가 있는 것으로 알려진 depudecin과 동일한 물질로 추정되었다. 본 실험에서 분리된 depudecin은 인체간암세포와 mouse 피부암세포에 대한 세포독성을 나타내었으며, 각각의$ IC_50$$57\mu$g/ml, $69\mu$g/ml로 나타났다. Alternaria brassicicola SW-3에 의해 생산된 물질이 기지의 물질이지만, depudecin은 아직 작용 기작이나 적용범위 등이 밝혀지지 않은 초기 연구 단계에 있는 물질로서, 새로운 항암제로서의 가능성이 매우 높아 이의 유도체를 합성하거나, 다른 항암제와의 혼용에 의해 부작용이 적은 강력한 항암제를 개발하기 위한 선도물질로 활용될 수 있을 것이다.

Keywords

References

  1. Miyadaoh, S. 1993. Research on antibiotics screening in Japan over the last decade: a producing microorganism approach. J Actinomycetol. 7: 100-106.
  2. Tsuruo, T., T. OH-hara, H. lida, S. Tsukagoshi, Z. Sato, I. Matsuda, S. Iwasaki, F. Shimizu, K. Sasagawa, M. Fukami, K. Fukuda, and M. Arakawa. 1986. Rhizoxin, a macrocyclic lactone antibiotic, as a new antitumor agent against human and murine tumor cells and their vincristine-resistant sublines. Cancer Res. 46: 381-385.
  3. Udagawa, T., J. Yuan, D. Panigraphy, Y. H. Chang, J. Shah, and R. J. D'Amato. 2000. Cytochalasin E, an epoxide containing Aspel;gillus-derived fungal metabolite, inhibits angiogenesis and tumor growth. .J Pharmacol Exp. Ther. 294: 421 -427.
  4. Han, J W, S. H. Ahn, S. H. Park, S. Y. Wang, G. U. Bae, D. W. Seo, H. K. Kim, S. Hong, H. Y. Lee, Y. W. Lee, and H. W. Lee. 2000. Apicidin, a histone deacetylase inhibitor, inhibits proliferation of tumor cells via induction of p21WAF1/Cip1 and gelsolin. Cancer Res. 60: 6068-6074.
  5. Satoshi Omura. 1992. The search for bioactive compounds from microorganisms, Springer Verlag, New York.
  6. King, A D. Jr. and J. E. Shade. 1984. Alternaria toxins and their importance in food. .J Food Prot. 47: 886.
  7. Rotem, J. 1994. The Genus Alternaria, biology, epidemiology and pathogenicity. APS press, St. Paul, MN
  8. Ciegler, A and A Laxdenfelser. 1969. An antibiotics complex from A. brassicicola. Experienta 25: 719.
  9. Matsumoto, M., S. Matsutani, K. Sugita, H. Yoshida, F. Hayashi, Y. Terui, H. Nakai, N. Uotani, Y. Kawamura, K. Matsumoto, J Shoji, and T. Yoshida. 1992. Depudecin: a novel compound inducing the flat phenotype of NIH3T3 cells doubly transformed by ras- and src-oncogene, produced by Alternaria brassicicola. .J Antibiotcs 45: 879-885.
  10. Oikawa, T., C. Onozawa, M. Inose, and M. Sasaki. 1995. Depudecin, a microbial metabolite containing two epoxide groups, exhibits anti-angiogenic activity in vivo. Bioi. Pharm. Bull. 18: 1305.
  11. Privalsky, M. L. 1998. Depudecin makes a debut Proc. Nat!. Acad. Sci. USA. 95: 3335-7. https://doi.org/10.1073/pnas.95.7.3335
  12. Kwon, H. J., T. Owa, C. A Hassig, J. Shimada, and S. L. Schreiber. 1998. Depudecin induces morphological reversion of transformed fibroblasts via the inhibition of histone deacetylase. Proc. Natl. Acad. Sci. USA 95: 3356-3361.
  13. Shimada, J., H. J. Kwon, Sawamura M., and S. L. Schreiber. 1995. Synthesis and cellular characterization of the detransformation agent, (-)-depudecin. ChemBioi 2: 517-25.
  14. Tanaka, M., T. Fujimori, and K. Nabeta. 2000. Biosynthesis of depudecin, a metabolite of Nimbya scirpicola. Biosci. Biotechno!. Biochem. 64: 244-247.
  15. Scudiero, D. A, R. H. Shoemaker, K. D. Paul, A Monks, S. Tierney, T. H. Nofziger, M. J. Currens, D. Seniff, and M. R. Boyd. 1988. Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. Cacer Res. 48: 4827-4833.
  16. Tanaka, M., J. Ohra, Y. Tsujino, Y. Sawaji, and T. Fujimori. 1994. Phytotoxin produced by Nimbya scirpicola. Biosci. Biotechnol. Biochem. 58: 565-566.
  17. Isaka, M. A Jaturapat, W. Kladwang, J. Punya, Y. Lertwerawat, M. Tanticharoen, and Y. Thebtaranonth. 2000. Antiplasmodial compounds from the wood-decayed fungus Xylaria sp. BCC 1067. Planta Med. 66: 473-475.